Bosh sahifaDMYD-B • STO
add
Diamyd Medical AB
Yopilish kursi
18,16 kr
Kunlik diapazon
17,88 kr - 18,70 kr
Yillik diapazon
7,65 kr - 25,00 kr
Bozor kapitalizatsiyasi
1,83 mlrd SEK
Oʻrtacha hajm
226,52 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | avg, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 19,00 ming | -74,32% |
Joriy xarajat | 51,15 mln | 40,41% |
Sof foyda | -49,74 mln | -32,60% |
Sof foyda marjasi | -261,79 ming | -416,43% |
Har bir ulushga tushum | — | — |
EBITDA | -50,48 mln | -40,02% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | avg, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 132,37 mln | 3,79% |
Jami aktivlari | 217,04 mln | 5,46% |
Jami passivlari | 71,12 mln | 95,32% |
Umumiy kapital | 145,92 mln | — |
Tarqatilgan aksiyalar | 104,09 mln | — |
Narxi/balansdagi bahosi | 12,44 | — |
Aktivlardan daromad | -55,84% | — |
Kapitaldan daromad | -76,10% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | avg, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -49,74 mln | -32,60% |
Operatsiyalardan naqd pul | -29,16 mln | 15,53% |
Sarmoyadan naqd pul | 18,79 mln | 886,03% |
Moliyadan naqd pul | -838,00 ming | -100,97% |
Naqd pulning sof oʻzgarishi | -10,27 mln | -120,46% |
Boʻsh pul | -18,28 mln | 27,58% |
Haqida
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
28
